BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 11998874)

  • 1. Repeated isolation of Cryptococcus laurentii from the oropharynx of an immunocompromized patient.
    Bauters TG; Swinne D; Boekhout T; Noens L; Nelis HJ
    Mycopathologia; 2002; 153(3):133-5. PubMed ID: 11998874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fungemia in a cancer patient caused by fluconazole-resistant Cryptococcus laurentii.
    Averbuch D; Boekhoutt T; Falk R; Engelhard D; Shapiro M; Block C; Polacheck I
    Med Mycol; 2002 Oct; 40(5):479-84. PubMed ID: 12462527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fungaemia due to Cryptococcus laurentii and a review of non-neoformans cryptococcaemia.
    Johnson LB; Bradley SF; Kauffman CA
    Mycoses; 1998; 41(7-8):277-80. PubMed ID: 9861831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous Cryptococcus laurentii infection in an immunocompetent child.
    Molina-Leyva A; Ruiz-Carrascosa JC; Leyva-Garcia A; Husein-Elahmed H
    Int J Infect Dis; 2013 Dec; 17(12):e1232-3. PubMed ID: 23791224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fungaemia due to Cryptococcus laurentii as a complication of immunosuppressive therapy--a case report.
    Furman-Kuklińska K; Naumnik B; Myśliwiec M
    Adv Med Sci; 2009; 54(1):116-9. PubMed ID: 19482727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invasive Cryptococcus laurentii disease in a nine-year-old boy with X-linked hyper-immunoglobulin M syndrome.
    Simon G; Simon G; Erdös M; Maródi L
    Pediatr Infect Dis J; 2005 Oct; 24(10):935-7. PubMed ID: 16220101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined antifungal therapy against systemic murine infections by rare Cryptococcus species.
    Thomson P; Mayayo E; López-Fernández L; Guarro J; Capilla J
    Mycoses; 2017 Feb; 60(2):112-117. PubMed ID: 27696562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary cutaneous cryptococcosis due to Cryptococcous laurentii in a renal transplant recipient.
    Kulkarni A; Sinha M; Anandh U
    Saudi J Kidney Dis Transpl; 2012 Jan; 23(1):102-5. PubMed ID: 22237228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cryptococcus laurentii fungemia.
    Banerjee P; Haider M; Trehan V; Mishra B; Thakur A; Dogra V; Loomba P
    Indian J Med Microbiol; 2013; 31(1):75-7. PubMed ID: 23508435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of nosocomial
    Salazar-Leal JI; Ramírez-Montelongo SM; López Luis BA
    Infect Control Hosp Epidemiol; 2019 Dec; 40(12):1442-1444. PubMed ID: 31566144
    [No Abstract]   [Full Text] [Related]  

  • 11. Fluconazole resistance in cryptococcal disease: emerging or intrinsic?
    Cheong JW; McCormack J
    Med Mycol; 2013 Apr; 51(3):261-9. PubMed ID: 22989195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fungaemia due to thermophilic cryptococci: 3 cases of Cryptococcus laurentii bloodstream infections in cancer patients receiving antifungals.
    Kunova A; Krcmery V
    Scand J Infect Dis; 1999; 31(3):328. PubMed ID: 10482072
    [No Abstract]   [Full Text] [Related]  

  • 13. Invasive fungal infection by Cryptococcus neoformans var. grubii with bone marrow and meningeal involvement in a HIV-infected patient: a case report.
    Vechi HT; Theodoro RC; de Oliveira AL; Gomes RMODS; Soares RDA; Freire MG; Bay MB
    BMC Infect Dis; 2019 Mar; 19(1):220. PubMed ID: 30832607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First report of Cryptococcus laurentii meningitis and a fatal case of Cryptococcus albidus cryptococcaemia in AIDS patients.
    Kordossis T; Avlami A; Velegraki A; Stefanou I; Georgakopoulos G; Papalambrou C; Legakis NJ
    Med Mycol; 1998 Oct; 36(5):335-9. PubMed ID: 10075504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic review of fluconazole resistance in clinical isolates of Cryptococcus species.
    Bongomin F; Oladele RO; Gago S; Moore CB; Richardson MD
    Mycoses; 2018 May; 61(5):290-297. PubMed ID: 29377368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response to therapy in patients with cryptococcosis and AIDS: Association with in vitro susceptibility to fluconazole.
    Agudelo CA; Muñoz C; Ramírez A; Tobón AM; de Bedout Bact C; Cano LE; Restrepo A
    Rev Iberoam Micol; 2015; 32(4):214-20. PubMed ID: 25637338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluconazole resistance is not a predictor of poor outcome in patients with cryptococcosis.
    Vena A; Muñoz P; Guinea J; Escribano P; Peláez T; Valerio M; Bonache F; Gago S; Álvarez-Uría A; Bouza E
    Mycoses; 2019 May; 62(5):441-449. PubMed ID: 30184276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MICs and minimum fungicidal concentrations of posaconazole, voriconazole and fluconazole for Cryptococcus neoformans and Cryptococcus gattii.
    Torres-Rodríguez JM; Alvarado-Ramírez E; Murciano F; Sellart M
    J Antimicrob Chemother; 2008 Jul; 62(1):205-6. PubMed ID: 18375969
    [No Abstract]   [Full Text] [Related]  

  • 19. Edematous erythema, subcutaneous plaques, and severe pain in the lower extremities in an immunocompromised patient.
    Ding YG; Fang H
    JAMA; 2013 Apr; 309(15):1632-3. PubMed ID: 23592108
    [No Abstract]   [Full Text] [Related]  

  • 20. Cryptococcus laurentii fungemia in a low birth weight preterm neonate: India.
    Gupta M; Mishra AK; Singh SK
    J Infect Public Health; 2018; 11(6):896-897. PubMed ID: 29731340
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.